Search

Your search keyword '"Kramberger, Milica G"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Kramberger, Milica G" Remove constraint Author: "Kramberger, Milica G" Publisher wiley Remove constraint Publisher: wiley
42 results on '"Kramberger, Milica G"'

Search Results

1. Sex differences in brain atrophy in dementia with Lewy bodies

6. Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European‐DLB consortium project

7. Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?

8. European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

9. The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD

10. Data‐assisted differential diagnosis of dementia by deep neural networks using MRI: A study from the European DLB consortium

13. Pre‐screening models for patient engagement: The MOPEAD project

14. The reliability of a deep learning model in external memory clinic MRI data: A multi‐cohort study

16. Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

17. Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

19. Metabolic patterns across core features in dementia with lewy bodies

21. P3‐603: SEX DIFFERENCES IN ACUTE STROKE CARE

23. P3‐304: MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER'S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES

27. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

28. Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

29. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

30. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

31. P3-209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study

33. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

34. O5-03-04: Clinical characteristics and course of dlb: Results from a large longitudinal multicentre cohort

35. EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

42. European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment.

Catalog

Books, media, physical & digital resources